MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis

Jiaofeng Huang,1,* Wenjuan Xue,2,* Mingfang Wang,1 Yinlian Wu,1 Medha Singh,3 Yueyong Zhu,1,4 Rahul Kumar,5 Su Lin1 1Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, People’s Republic of China;...

Full description

Bibliographic Details
Main Authors: Huang J, Xue W, Wang M, Wu Y, Singh M, Zhu Y, Kumar R, Lin S
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
metabolic associated fatty liver disease
nonalcoholic fatty liver disease
metabolic risks
lean nafld
biopsy
Online Access:https://www.dovepress.com/mafld-criteria-may-overlook-a-subtype-of-patient-with-steatohepatitis--peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/mafld-criteria-may-overlook-a-subtype-of-patient-with-steatohepatitis--peer-reviewed-fulltext-article-DMSO

Similar Items